Trusted Resources: Education

Scientific literature and patient education texts

Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome): Defining and Measuring Functional Impacts in Pediatric Patients

key information

source: Orphanet journal of rare diseases

year: 2021

authors: Leiro B,Phillips D,Duiker M,Harmatz P,Charles S

summary/abstract:

Research about pediatric patients’ perspective on mucopolysaccharidosis type VI (MPS VI) and its impact on daily life is limited. We aimed to identify the disease concepts of interest that most impact function and day-to-day life of pediatric patients with MPS VI, and to consider clinical outcome assessments (COAs) that may potentially measure meaningful improvements in these concepts.

organization: Phillips Consulting, Chapel Hill, NC, USA. beth.leiro@gmail.com.

DOI: 10.1186/s13023-021-02113-8

read more